Diabetic vitrectomy in a large type 1 diabetes patient population: Long-term incidence and risk factors

Acta Ophthalmologica

Volumn 92, Issue 5, 2014, Pages 439-443

  Ostri, Christoffer ^a   La Cour, Morten ^a   Lund Andersen, Henrik ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

Author keywords

diabetes; diabetic retinopathy; diabetic vitrectomy; incidence; metabolic control; panretinal laser; risk factors; scatter laser; vitrectomy

Indexed keywords

HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GENDER; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA DETACHMENT; RETROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION; VITRECTOMY; VITREOUS HEMORRHAGE; BLOOD; BLOOD PRESSURE; DENMARK; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GLUCOSE BLOOD LEVEL; LASER COAGULATION; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; REGISTER; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; DENMARK; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; LASER COAGULATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; VITRECTOMY; YOUNG ADULT;

EID: 84904731521     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12249     Document Type: Article

References (21)

1. Abbate M, Cravedi P, Iliev I, Remuzzi G, &, Ruggenenti P, (2011): Prevention and treatment of diabetic retinopathy: evidence from clinical trials and perspectives. Curr Diabetes Rev 7: 190-200.
2. Aldington SJ, Kohner EM, Meuer S, Klein R, &, Sjolie AK, (1995): Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia 38: 437-444.
3. Bek T, &, Erlandsen M, (2006): Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy. Acta Ophthalmol 84: 16-20. (Pubitemid 43337468)
4. Chase HP, Garg SK, Jackson WE, Thomas MA, Harris S, Marshall G, &, Crews MJ, (1990): Blood pressure and retinopathy in type I diabetes. Ophthalmology 97: 155-159. (Pubitemid 20051376)
5. Danish Health and Medicines Authority (2003): The Danish national patient register 1977-2002. Report Available at: http://www.sst.dk/English.aspx.
6. Diabetes Control Complications Trial (1995): The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 113: 36-51.
7. Diabetic Retinopathy Study Research Group (1987): Indications for photocoagulation treatment of diabetic retinopathy: diabetic Retinopathy Study Report no. 14. Int Ophthalmol Clin 27: 239-253.
8. Early Treatment Diabetic Retinopathy Study Research Group (1991): Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 98: 766-785.
9. Flynn HW, Chew EY, Simons BD, Barton FB, Remaley NA, Ferris FL III, (1992): Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. Ophthalmology 99: 1351-1357.
10. Hansen AB, Hansen RN, Colding-Jorgensen M, Borch-Johnsen K, &, Lund-Andersen H, (2005): Model simulation of the patient flow through a screening centre for diabetic retinopathy. Acta Ophthalmol Scand 83: 678-686. (Pubitemid 41819290)
11. Klein R, Klein BE, Moss SE, Davis MD, &, DeMets DL, (1984): The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-526. (Pubitemid 14127838)
12. Klein R, Klein BE, Moss SE, Davis MD, &, DeMets DL, (1989): The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 107: 237-243. (Pubitemid 19055344)
13. Klein BE, Klein R, Moss SE, &, Palta M, (1995): A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch Ophthalmol 113: 601-606.
14. Lovestam-Adrian M, Agardh CD, Torffvit O, &, Agardh E, (2001): Diabetic retinopathy, visual acuity, and medical risk indicators: a continuous 10-year follow-up study in Type 1 diabetic patients under routine care. J Diabetes Complications 15: 287-294. (Pubitemid 33065670)
15. Mehlsen J, Erlandsen M, Poulsen PL, &, Bek T, (2011): Identification of independent risk factors for the development of diabetic retinopathy requiring treatment. Acta Ophthalmol 89: 515-521.
16. National Committee on Quality Assurance (2012): Diabetes recognition program. Report Available at: www.ncqa.org/tabid/1023/Default.aspx.
17. Reddy VM, Zamora RL, &, Olk RJ, (1995): Quantitation of retinal ablation in proliferative diabetic retinopathy. Am J Ophthalmol 119: 760-766.
18. Shaw JE, Sicree RA, &, Zimmet PZ, (2010): Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4-14.
19. Statistics Denmark (2013): StatBank Denmark, population and elections. Public Available at: http://www.dst.dk/en/Statistik.aspx.
20. Steno Diabetes Center (2012): Activity report 2011. Report Available at: http://www.stenodiabetescenter.com/documents/home-page/document/index.asp.
21. UK Prospective Diabetes Study Group (1998): Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837-853.